Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Quinolinone derivative and preparation method and application thereof

A technology of quinolinone and its derivatives, which is applied in the field of quinolinone derivatives and their preparation, and can solve the problems of less research

Active Publication Date: 2015-03-25
SUZHOU HIGHFINE BIOTECH
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Quinoline structures exist in many drug molecules, but GPR119 agonists have less research on quinolines

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Quinolinone derivative and preparation method and application thereof
  • Quinolinone derivative and preparation method and application thereof
  • Quinolinone derivative and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0018] The preparation process of quinolinone derivatives of the present invention is shown in following synthetic route:

[0019]

[0020] Among them, R means C 1 -C 4 Hydrocarbyl.

Embodiment 1

[0022] Synthetic formula III compound

[0023]

[0024] Add 10g (62.2mmol) of compound of formula II to 200mL of N,N-dimethylformamide, then add 12.88g (93.4mmol) of potassium carbonate and 7.6mL (62.2mmol) of benzyl bromide, and heat to 100°C for reaction 5 Hour. The system was poured into water, filtered, dried, and the crude product was refluxed in ethyl acetate to obtain 7.0 g of white solid, namely the compound of formula III, with a yield of 44.8%.

Embodiment 2

[0026] Synthetic formula IV compound

[0027]

[0028] 3g (11.9mmol) formula III compound, 9g (38.5mmol) p-thymphenyl bromobenzene, cuprous iodide (5.1mmol), 720mg (5.0mmol) 8-hydroxyquinoline and 4.08g (29.6mmol) potassium carbonate Dissolve in 100 mL of anhydrous dimethyl sulfoxide, under nitrogen protection, heat up to 130°C, and react for 8 hours. After the reaction was completed, it was poured into water, filtered, and the filter cake was refluxed with ethyl acetate to obtain 1.9 g of a white solid, namely compound IV, with a yield of 40%.

[0029] 1 H NMR (400MHz, CDCl 3 )δ8.18(d, J=7.9Hz, 2H), 8.09(d, J=7.9Hz, 1H), 7.59–7.31(m, 8H), 7.23(d, J=7.6Hz, 1H), 6.56( d, J=8.5Hz, 1H), 6.18(s, 1H), 5.25(s, 2H), 3.15(s, 3H).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a quinolinone derivative as shown in a general formula I and a preparation method thereof, wherein R indicates C1-C4 alkyl. The invention also provides application of the quinolinone derivative as a GPR119 excitant and in preparing a drug for treating diabetes. The compound provided by the invention has certain biological activity and most importantly, the compound provided by the invention is a novel GPR119 excitant with good physicochemical properties.

Description

technical field [0001] The invention relates to the field of chemical medicines, and more particularly relates to a quinolinone derivative and its preparation method and application. Background technique [0002] Diabetes mellitus is a systemic metabolic disorder caused by absolute or relative insufficiency of insulin in the blood and decreased sensitivity of target cells to insulin. It is usually divided into two types: type I and type II. Type II diabetes accounts for more than 90% of all diabetes cases and is a serious progressive disease that causes microvascular complications (including retinopathy, neuropathy and nephropathy) and macrovascular complications (including accelerated arteriosclerosis, coronary heart disease and stroke). [0003] The treatment of type I diabetes mainly relies on insulin injection, and the development of drugs for type II diabetes is the primary task of overcoming diabetes. Defective islet β-cell function is the main cause of type II diabet...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D401/12A61K31/4709A61P3/10
CPCC07D401/12
Inventor 吕敏杰张海燕王桂春
Owner SUZHOU HIGHFINE BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com